Single GLP-1 receptor agonists act on one incretin pathway, while dual GIP/GLP-1 agonists target two pathways
We emphasize a holistic approach, combining this medication with a healthy diet and regular physical activity to ensure the best outcomes for our patients
If you have an Affordable Care (Health Care Exchange) plan, you may still be qualified to receive and use this savings card
Visceral fat is metabolically active fat stored around abdominal organs that increases risk for insulin resistance, cardiovascular disease, and metabolic complications
First, we documented that our siRNA approach reduced Mtpa mRNA levels by 76% and MTP protein by 67% in caSMCs and compared the results with those obtained with the negative control siRNA (Figure 7, A and B)
PlushCare cannot enroll patients in this trial Learn more about our medical weight loss programs, including weight loss medications for qualifying patients